X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
http://www.pharmafile.com/news/626214/gesynta-pharma-receives-orphan-drug-designation-fda-systemic-sclerosis
http://www.pharmafile.com/news/626214/gesynta-pharma-receives-orphan-drug-designation-fda-systemic-sclerosis
https://news.cision.com/let-em-know-ab/r/gesynta-pharma-announces-significant-progress-across-development-program-for-first-in-class-drug-can,c3366291#:~:text=Stockholm%2C%20Sweden%2C%20June%2014%202021,in%20patients%20with%20systemic%20sclerosis.
https://nordiclifescience.org/gesynta-pharma-initiates-phase-ii-study/#:~:text=Gesynta%20Pharma%20has%20announced%20that,in%20patients%20with%20systemic%20sclerosis.&text=This%20proof%2Dof%2Dconcept%20study,flow%20in%20this%20patient%20group.
Market Place
Share 
